93. 原発性胆汁性胆管炎 ［臨床試験数：230，薬物数：215（DrugBank：51），標的遺伝子数：34，標的パスウェイ数：107］
Searched query = "Primary biliary cholangitis", "Primary biliary cirrhosis", "PBC"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
|1||NCT00844402||January 2006||13/2/2009||Safety and Efficacy of Long-Term Treatment With Atorvastatin in Patients With Primary Biliary Cirrhosis||Safety and Efficacy of Long-Term Treatment With Atorvastatin in Patients With Primary Biliary Cirrhosis||Primary Biliary Cirrhosis;Hypercholesterolemia||Drug: Atorvastatin||Medical University of Graz||NULL||Completed||18 Years||70 Years||Both||40||Phase 3||Austria|
|2||EUCTR2005-002160-28-AT||23/09/2005||19/08/2005||Safety and efficacy of long-term treatment with atorvastatin in patients with primary biliary cirrhosis||Safety and efficacy of long-term treatment with atorvastatin in patients with primary biliary cirrhosis||Reduction of cardiovascular risk may become key for the management of PBC. Therefore information on safety and efficacy (lipid-lowering effects) of statins in chronic cholestatic disorders is essential. Moreover, the study will answer the open question whether long-term treatment with statins may have potential beneficial effects on the course of PBC.||Trade Name: Sortis|
Product Name: Sortis 10 mg
INN or Proposed INN: Atorvastatin
|Medical University Graz,Department of Internal Medicine, Division of Gastroenterology and Hepatology||NULL||Not Recruiting||Female: yes|